MLYS — Mineralys Therapeutics, Inc. stock price, charts and financials

QT50Mineralys Therapeutics, Inc.

Mineralys Therapeutics, Inc. (NASDAQ: MLYS) is a Healthcare company in the Biotechnology industry. QuoTrend tracks its price, financials, earnings, analyst ratings and insider trades.

Latest market price
28.02
+0.04+0.14%
OverviewShort InterestFilings
MLYSQT50Mineralys Therapeutics, Inc.·NASDAQ
28.02+0.14%

Latest SEC Filings

Form category
Filing Date ▾FormDescriptionFilingDocument
Sep 17, 20264Statement of changes in beneficial ownership
Aug 25, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20264Statement of changes in beneficial ownership
Aug 12, 20263Initial statement of beneficial ownership
Aug 11, 20268-KCurrent report
Aug 11, 202610-QQuarterly report
Aug 06, 2026SC 13G/ABeneficial ownership statement (passive, amended)
Jul 23, 20264Statement of changes in beneficial ownership
Jul 20, 20264Statement of changes in beneficial ownership
Jul 15, 20264Statement of changes in beneficial ownership
Jul 15, 20264Statement of changes in beneficial ownership
Jul 10, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 30, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 17, 20264Statement of changes in beneficial ownership
Jun 12, 20264Statement of changes in beneficial ownership
Jun 03, 20268-KCurrent report
May 22, 20268-KCurrent report
May 19, 20264Statement of changes in beneficial ownership
May 13, 20264Statement of changes in beneficial ownership
May 06, 20268-KCurrent report
May 06, 202610-QQuarterly report
Apr 21, 20264Statement of changes in beneficial ownership
#1 / 25 of 298
Page
▼
/ 12